363 research outputs found
An algorithm for collapsing sign alternating sequences of real numbers
AbstractA table with two rows and n columns may be thought of as two vectors with n components. The distance between the two rows then corresponds to the norm of the difference between the rows. We examine the problem of how to collapse the adjacent columns of the table while keeping the norm of the difference as large as possible. First a stepwise algorithm is given which achieves this end with respect to the norm of the vector of differences. After proving the optimality of the stepwise solution we extend the result to the norm which arises from minimizing the number of persons misclassified. The same algorithm suffices
Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Photoimmunotherapy (PIT) of cancer utilizes tumor-specific monoclonal antibodies conjugated to a photosensitizer phthalocyanine dye IR700 which becomes cytotoxic upon irradiation with near infrared light. In this study, we aimed to evaluate the efficacy of PIT on human pancreatic cancer cells in vitro and in vivo in an orthotopic nude mouse model. The binding capacity of anti-CEA antibody to BxPC-3 human pancreatic cancer cells was determined by FACS analysis. An in vitro cytotoxicity assay was used to determine cell death following treatment with PIT. For in vivo determination of PIT efficacy, nude mice were orthotopically implanted with BxPC-3 pancreatic tumors expressing green fluorescent protein (GFP). After tumor engraftment, the mice were divided into two groups: (1) treatment with anti-CEA-IR700 + 690 nm laser and (2) treatment with 690 nm laser only. Anti-CEA-IR700 (100 ÎŒg) was administered to group (1) via tail vein injection 24 hours prior to therapy. Tumors were then surgically exposed and treated with phototherapy at an intensity of 150 mW/cm2 for 30 minutes. Whole body imaging was done subsequently for 5 weeks using an OV-100 small animal imaging system. Anti-CEA-IR700 antibody bound to the BxPC3 cells to a high degree as shown by FACS analysis. Anti-CEA-IR700 caused extensive cancer cell killing after light activation compared to control cells in cytotoxicity assays. In the orthotopic models of pancreatic cancer, the anti-CEA-IR700 group had significantly smaller tumors than the control after 5 weeks (p<0.001). There was no significant difference in the body weights of mice in the anti-CEA-IR700 and control groups indicating that PIT was well tolerated by the mice
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis
OBJECTIVE: Improved biomarkers of current disease activity and prediction of relapse are needed in antineutrophil cytoplasmic antibodyâassociated vasculitis (AAV). For clinical relevance, biomarkers must perform well longitudinally in patients on treatment and in patients with nonsevere flares. METHODS: Twentyâtwo proteins were measured in 347 serum samples from 74 patients with AAV enrolled in a clinical trial. Samples were collected at Month 6 after remission induction, then every 3 months until Month 18, or at the time of flare. Associations of protein concentrations with concurrent disease activity and with future flare were analyzed using mixedâeffects models, Cox proportional hazards models, and conditional logistic regression. RESULTS: Fortyâtwo patients had flares during the 12âmonth followâup period, and 32 remained in remission. Twentyâtwo patients had severe flares. Six experimental markers (CXCL13, ILâ6, ILâ8, ILâ15, ILâ18BP, and matrix metalloproteinaseâ3 [MMPâ3]) and ESR were associated with disease activity using all three methods (P <â0.05, with P <â0.01 in at least one method). A rise in ILâ8, ILâ15, or ILâ18BP was associated temporally with flare. Combining Câreactive protein (CRP), ILâ18BP, neutrophil gelatinaseâassociated lipocalin (NGAL), and sILâ2Rα improved association with active AAV. CXCL13 and MMPâ3 were increased during treatment with prednisone, independent of disease activity. Marker concentrations during remission were not predictive of future flare. CONCLUSION: Serum biomarkers of inflammation and tissue damage and repair have been previously shown to be strongly associated with severe active AAV were less strongly associated with active AAV in a longitudinal study that included mild flares and varying treatment. Markers rising contemporaneously with flare or with an improved association in combination merit further study
A SAS macro for a clustered logrank test
The clustered logrank test is a nonparametric method of significance testing for correlated survival data. Examples of its application include cluster randomized trials where groups of patients rather than individuals are randomized to either a treatment or control intervention. We describe a SAS macro that implements the 2-sample clustered logrank test for data where the entire cluster is randomized to the same treatment group. We discuss the theory and applications behind this test as well as details of the SAS code
A comparison of statistical approaches for physician-randomized trials with survival outcomes
This study compares methods for analyzing correlated survival data from physician-randomized trials of health care quality improvement interventions. Several proposed methods adjust for correlated survival data however the most suitable method is unknown. Applying the characteristics of our study example, we performed three simulation studies to compare conditional, marginal, and non-parametric methods for analyzing clustered survival data. We simulated 1,000 datasets using a shared frailty model with (1) fixed cluster size, (2) variable cluster size, and (3) non-lognormal random effects. Methods of analyses included: the nonlinear mixed model (conditional), the marginal proportional hazards model with robust standard errors, the clustered logrank test, and the clustered permutation test (non-parametric). For each method considered we estimated Type I error, power, mean squared error, and the coverage probability of the treatment effect estimator. We observed underestimated Type I error for the clustered logrank test. The marginal proportional hazards method performed well even when model assumptions were violated. Nonlinear mixed models were only advantageous when the distribution was correctly specified
Recommended from our members
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
BACKGROUND We previously reported prolonged progression-free survival and marginally prolonged overall survival among postmenopausal patients with hormone receptor-positive metastatic breast cancer who had been randomly assigned to receive the aromatase inhibitor anastrozole plus the selective estrogen-receptor down-regulator fulvestrant, as compared with anastrozole alone, as first-line therapy. We now report final survival outcomes. METHODS We randomly assigned patients to receive either anastrozole or fulvestrant plus anastrozole. Randomization was stratified according to adjuvant tamoxifen use. Analysis of survival was performed by means of two-sided stratified log-rank tests and Cox regression. Efficacy and safety were compared between the two groups, both overall and in subgroups. RESULTS Of 707 patients who had undergone randomization, 694 had data available for analysis. The combination-therapy group had 247 deaths among 349 women (71%) and a median overall survival of 49.8 months, as compared with 261 deaths among 345 women (76%) and a median overall survival of 42.0 months in the anastrozole-alone group, a significant difference (hazard ratio for death, 0.82; 95% confidence interval (CIS, 0.69 to 0.98; P=0.03 by the log-rank test). In a subgroup analysis of the two strata, overall survival among women who had not received tamoxifen previously was longer with the combination therapy than with anastrozole alone (median, 52.2 months and 40.3 months, respectively; hazard ratio, 0.73; 95% CI, 0.58 to 0.92); among women who had received tamoxifen previously, overall survival was similar in the two groups (median, 48.2 months and 43.5 months, respectively; hazard ratio, 0.97; 95% CI, 0.74 to 1.27) (P=0.09 for interaction). The incidence of long-term toxic effects of grade 3 to 5 was similar in the two groups. Approximately 45% of the patients in the anastrozole-alone group crossed over to receive fulvestrant. CONCLUSIONS The addition of fulvestrant to anastrozole was associated with increased long-term survival as compared with anastrozole alone, despite substantial crossover to fulvestrant after progression during therapy with anastrozole alone. The results suggest that the benefit was particularly notable in patients without previous exposure to adjuvant endocrine therapy.National Cancer Institute; AstraZeneca6 month embargo; published 28 March 2019.This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]
Lacunarity, lexicography and beyond: integration of the introduction of a linguo-cultural concept and the development of L2 learnersâ dictionary skills
The paper discusses the integration of presenting theoretical linguocultural
knowledge and developing dictionary skills in advanced students of a
foreign language. The proposed approach allows showing students the interdisciplinary
character of various issues, one of which is cross-linguistic lacunarity. It is
given as an example of a phenomenon, whose introduction can be combined with
the development of studentsâ dictionary use abilities. Lacunarity consists in the lack
of some source language elements in the target language. Two main kinds of
lacunae are distinguished: linguistic and referential ones. The focal issue of the
paper is how the information on the lacunary character of words can be presented to
advanced students of English as a foreign language, in this paper Polish learners, so
that they could consider the phenomenon in terms of bilingual lexicography: first,
becoming aware of the specifics of their description; second, practising their dictionary
skills by analysing entries for selected lacunary lexical and phraseological
units; third, combining the information and skills in doing creative tasks, related to
lacunarity and its bilingual lexicographic descriptions. Furthermore, additional
activities are proposed for revising the acquired knowledge on lacunarity and
advancing dictionary use. Offering students tasks, which require them to adopt a
different perspective, aims to increase their involvement in the learning process and
to foster their autonomy as learners. Encouraging learners to reflect on lacunae and
their lexicographic description is expected to familiarize them with the phenomenon
and simultaneously to develop their dictionary skills by doing especially designed
[email protected] University of Bialystok101-11
A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen
Background Clinical trials are widely considered
the gold standard in comparative effectiveness research (CER) but the high cost
and complexity of traditional trials and concerns about generalizability to
broad patient populations and general clinical practice limit their appeal.
Unsuccessful implementation of CER results limits the value of even the highest
quality trials. Planning for a trial comparing two standard strategies of
insulin administration for hospitalized patients led us to develop a new method
for a clinical trial designed to be embedded directly into the clinical care
setting thereby lowering the cost, increasing the pragmatic nature of the
overall trial, strengthening implementation, and creating an integrated
environment of research-based care
Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience
<p>Abstract</p> <p>Background</p> <p>Epilepsy is associated with precocious development of Alzheimer-type neuropathological changes, including appearance of senile plaques, neuronal loss and glial activation. As inheritance of <it>APOE Δ4 </it>allele(s) is reported to favor this outcome, we sought to investigate neuronal and glial responses that differ according to <it>APOE </it>genotype. With an eye toward defining ways in which <it>APOE Δ3 </it>alleles may foster neuronal well-being in epilepsy and/or <it>APOE Δ4 </it>alleles exacerbate neuronal decline, neuronal and glial characteristics were studied in temporal lobectomy specimens from epilepsy patients of either <it>APOE Δ4,4 </it>or <it>APOE Δ3,3 </it>genotype.</p> <p>Methods</p> <p>Tissue and/or cellular expressions of interleukin-1 alpha (IL-1α), apolipoprotein E (ApoE), amyloid ÎČ (AÎČ) precursor protein (ÎČAPP), synaptophysin, phosphorylated tau, and AÎČ were determined in frozen and paraffin-embedded tissues from 52 <it>APOE Δ3,3 </it>and 7 <it>APOE Δ4,4 </it>(0.25 to 71 years) epilepsy patients, and 5 neurologically normal patients using Western blot, RT-PCR, and fluorescence immunohistochemistry.</p> <p>Results</p> <p>Tissue levels of IL-1α were elevated in patients of both <it>APOE Δ3,3 </it>and <it>APOE Δ4,4 </it>genotypes, and this elevation was apparent as an increase in the number of activated microglia per neuron (<it>APOE </it>Δ<it>3,3 </it>vs <it>APOE Δ4,4 </it>= 3.7 ± 1.2 vs 1.5 ± 0.4; <it>P </it>< 0.05). This, together with increases in ÎČAPP and ApoE, was associated with apparent neuronal sparing in that <it>APOE Δ4,4 </it>genotype was associated with smaller neuron size (<it>APOE Δ4,4 </it>vs <it>APOE Δ3,3 </it>= 173 ± 27 vs 356 ± 45; <it>P </it>†0.01) and greater DNA damage (<it>APOE Δ4,4 </it>vs <it>APOE Δ3,3 </it>= 67 ± 10 vs 39 ± 2; <it>P </it>= 0.01). 3) AÎČ plaques were noted at early ages in our epilepsy patients, regardless of <it>APOE </it>genotype (<it>APOE Δ4,4 </it>age 10; <it>APOE Δ3,3 </it>age 17).</p> <p>Conclusions</p> <p>Our findings of neuronal and glial events, which correlate with lesser neuronal DNA damage and larger, more robust neurons in epilepsy patients of <it>APOE Δ3,3 </it>genotype compared to <it>APOE Δ4,4 </it>genotype carriers, are consistent with the idea that the <it>APOE </it>Δ<it>3,3 </it>genotype better protects neurons subjected to the hyperexcitability of epilepsy and thus confers less risk of AD (Alzheimer's disease).</p> <p>Please see related article: <url>http://www.biomedcentral.com/1741-7015/10/36</url></p
- âŠ